| Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484) |
|---|
| 07/08/2003 | US6589984 Blood cholesterol and triglycerides (TG) themselves are generally insoluble in blood, and they exist as lipoproteins by binding with apolipoproteins. In the body, triglycerides are biosynthesized primarily in the liver from acetyl CoA as |
| 07/08/2003 | US6589983 Antiarrhythmic agents having the prolongation effect on the functional refractory period as a main function |
| 07/08/2003 | US6589979 Derivatives of seco-baccatine III, with bioavailability through the oral route, reduced toxicity and high antiangiogenetic activity; use as antiarthritic agent as well |
| 07/08/2003 | US6589978 Therapy for nervous system disorders |
| 07/08/2003 | US6589977 Bisindolylpyrrole derivatives represented by general formula (I) which are useful in inhibiting cell death and expected as being useful as preventives and remedies for the progress of various diseases in the progress and worsening of which cell |
| 07/08/2003 | US6589972 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects |
| 07/08/2003 | US6589970 6-(aryl-amido or aryl-amidomethyl)-naphthalen-2-yloxy-acidic derivatives as inhibitors of plasminogen activator inhibitor type-1 (PAI-1) |
| 07/08/2003 | US6589963 Drug salt thereof show a hypoglycemic action, a blood hypolipidemic action, an insulin resistance-improving action and a PPAR activating action, and are useful as a hypoglycemic agent, a hypolipidemic agent, an insulin |
| 07/08/2003 | US6589959 Crystalline bis[(e)-7-[4-(4-fluorophenyl)-6-isopropyl-2-[methyl(methylsulfonyl)amino]pyrimidin-5-yl](3R,5S)-3,5-dihydroxyhept-6-enoic acid]calcium salt |
| 07/08/2003 | US6589956 Its enantiomers, diastereoisomers, and addition salts thereof with a pharmaceutically acceptable acid or base, and medicinal products containing the same which are useful as a TXA2 receptor antagonist and 5-HT2 receptor antagonist. |
| 07/08/2003 | US6589954 Indoles, benzimidazoles and benztriazoles which are substituted at the 5 or 6 position with a substituent comprising an aromatic moiety linked through a piperazine ring to said indole, benzimidazole or benztriazole are useful |
| 07/08/2003 | US6589953 Indole derivatives as 5-HT1B and 5-HT1D agonists |
| 07/08/2003 | US6589950 Treatment of inflammatory or obstructive airways disease for respiratory system disorders |
| 07/08/2003 | US6589948 Cyclic salen-metal compounds: reactive oxygen species scavengers useful as antioxidants in the treatment and prevention of diseases |
| 07/08/2003 | US6589946 Bile salt conjugates |
| 07/08/2003 | US6589944 A method of cleaving glycation endproducts or cross-linked proteins in an organism in need thereof, wherein said method comprises administering an effective amount of a compound or pharmaceutically acceptable salt thereof to said organism for |
| 07/08/2003 | US6589938 Cardiovascular disorders |
| 07/08/2003 | US6589782 VEGF (Vascular Endothelial Growth Factor); adenovirus vector; Use in treating cardiovascular disorders, enhancing the neovascularization of diseased blood vessels and enhancing drug delivery via improved vascular permeability |
| 07/08/2003 | US6589748 Accurately measuring albumin in urine sample; obtain urine, detect presence of adjusted and wildtype albumin in sample |
| 07/08/2003 | US6589523 Agent for gene therapy of dilated cardiomyopathy |
| 07/08/2003 | US6589503 Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy |
| 07/08/2003 | CA2272640C Guanidinyl heterocycle compounds useful as alpha-2 adrenoceptor agonists |
| 07/08/2003 | CA2271841C 2-imidazolinylaminoindole compounds useful as alpha-2 adrenoceptor agonists |
| 07/07/2003 | CA2415591A1 Oxo or oxy-pyridine compounds as 5-ht4 receptor modulators |
| 07/03/2003 | WO2003054541A2 Inhibition of tristetraproline for protection of the heart from cardiac injuries |
| 07/03/2003 | WO2003054190A1 Novel proteins and dnas thereof |
| 07/03/2003 | WO2003054156A2 Novel g proein-coupled receptor, gave7 |
| 07/03/2003 | WO2003054077A1 Cereal beta glucan compositions, methods of preparation and uses thereof |
| 07/03/2003 | WO2003054012A2 Leptin proteins |
| 07/03/2003 | WO2003054009A2 Apoptotically active peptides |
| 07/03/2003 | WO2003053997A2 Methods of increasing endogenous erythropoietin (epo) |
| 07/03/2003 | WO2003053979A1 Novel benzothiazine and benzothiadiazine derivatives, method for preparing same and pharmaceutical compositions containing same |
| 07/03/2003 | WO2003053977A1 Tetracyclic heterocompounds as estrogen receptor modulators |
| 07/03/2003 | WO2003053975A1 Pyrazolopyrimidinone derivatives having pde7-inhibitory activity |
| 07/03/2003 | WO2003053974A1 Novel compounds and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
| 07/03/2003 | WO2003053973A1 Pyrazolyl-substituted triazoloquinoxalines |
| 07/03/2003 | WO2003053972A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053971A1 Pyridoquinoxaline antivirals |
| 07/03/2003 | WO2003053969A1 Imidazoquinoline derivatives |
| 07/03/2003 | WO2003053968A1 Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 07/03/2003 | WO2003053967A1 Aroyl pyridinones |
| 07/03/2003 | WO2003053961A1 Benzothiazoles |
| 07/03/2003 | WO2003053955A1 Thiochromenones used to combat painful conditions and neurodegenerative diseases |
| 07/03/2003 | WO2003053947A1 Benzothia(dia)zine derivatives and their use as ampa modulators |
| 07/03/2003 | WO2003053946A1 7-amino-benzothiazole derivatives as adenosine receptor ligands |
| 07/03/2003 | WO2003053941A2 Barbituric acid derivatives as inhibitors of tnf-alpha converting enzyme (tace) and/or matrix metalloproteinases |
| 07/03/2003 | WO2003053933A1 Heteroaryl-substituted aminocyclohexane derivatives |
| 07/03/2003 | WO2003053928A1 Serotonine reuptake inhibitor |
| 07/03/2003 | WO2003053926A1 Novel phenylalanine derivative |
| 07/03/2003 | WO2003053925A1 Pyrrolidine-2-ones as factor xa inhibitors |
| 07/03/2003 | WO2003053923A2 Pyrrolidine derivatives as prostaglandin modulators |
| 07/03/2003 | WO2003053919A1 Substituted cyclohexane derivatives |
| 07/03/2003 | WO2003053915A2 Compounds for the treatment of inflammatory disorders |
| 07/03/2003 | WO2003053911A1 Acetyl l-carnitine salt with a dicarboxilic organic acid and process for preparing same |
| 07/03/2003 | WO2003053467A1 Drug for regenerating tissue and vessel and method therefor |
| 07/03/2003 | WO2003053458A1 Use of a pharmaceutical composition containing epidermal growth factor (egf) for diabetic foot amputation prevention |
| 07/03/2003 | WO2003053444A1 New use |
| 07/03/2003 | WO2003053441A1 Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and the use of the same |
| 07/03/2003 | WO2003053439A1 Use of benzofuroxan derivatives as antiplatelet agents |
| 07/03/2003 | WO2003053437A1 Triazoles as oxytocin antagonists |
| 07/03/2003 | WO2003053434A1 Substituted imidazolidines, method for the production thereof, use thereof as a drug or for diagnosis, and drug containing substituted imidazolidines |
| 07/03/2003 | WO2003053425A1 Treatment of neurodegenerative and cardiovascular disorders |
| 07/03/2003 | WO2003053424A1 Use of a cysteine-containing substance to increase the ventilatory activity and erythropoietin production |
| 07/03/2003 | WO2003053407A1 Liposomal delivery of vitamin e based compounds |
| 07/03/2003 | WO2003053401A2 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 07/03/2003 | WO2003053368A2 Chalcone derivatives and their use to treat diseases |
| 07/03/2003 | WO2003053366A2 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 07/03/2003 | WO2003053364A2 Methods and compositions in treating pain and painful disorders using 1465,1587, 2146, 2207, 32838, 336 and 52908 |
| 07/03/2003 | WO2003053361A2 PYRROLOPYRIMIDINE A2b SELECTIVE ANTAGONIST COMPOUNDS, THEIR SYNTHESIS AND USE |
| 07/03/2003 | WO2003053359A2 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders |
| 07/03/2003 | WO2003053358A2 Fused heterocyclic compounds and analogs thereof: modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053354A2 Fused cyclic modulators of nuclear hormone receptor function |
| 07/03/2003 | WO2003053353A2 Administration of vasopeptidase inhibitors to reduce pulse pressure |
| 07/03/2003 | WO2003053352A2 Therapeutic compounds for treating dyslipidemic conditions |
| 07/03/2003 | WO2003053346A2 Systems and methods for treating patients with processed lipoaspirate cells |
| 07/03/2003 | WO2003053336A2 Methods for the treatment of peripheral neural and vascular ailments |
| 07/03/2003 | WO2003053330A2 Use of oxindole derivatives in the treatment of dementia related diseases, alzheimer’s disease and conditions associated with glycogen synthase kinase-3 |
| 07/03/2003 | WO2003053219A2 Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 07/03/2003 | WO2003053163A2 Salt composition with low sodium chloride and high organic potassium salt content and uses thereof |
| 07/03/2003 | WO2003020201A3 Pre-mixes of glp-1 and basal insulin |
| 07/03/2003 | WO2003013440A3 Treatment and prevention of heat shock protein-associated diseases and conditions |
| 07/03/2003 | WO2003010284A3 Antisense modulation of c-reactive protein expression |
| 07/03/2003 | WO2002072616A3 Transfection complexes |
| 07/03/2003 | WO2002070549A3 Chimeric polypeptides of serum albumin and uses related thereto |
| 07/03/2003 | WO2002058734A3 Combinations of sterol absorption inhibitor(s) with blood modifier(s) for treating vascular conditions |
| 07/03/2003 | WO2002058732A3 Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications |
| 07/03/2003 | WO2002050279A3 Nucleic acid-associated proteins |
| 07/03/2003 | WO2002024754A8 Polysaccharides with antithrombotic activity comprising at least a covalent bond with biotin or a biotin derivative |
| 07/03/2003 | WO2002022801A9 Mammalian receptor genes and uses |
| 07/03/2003 | WO2002018389A3 Thienopyrimidine |
| 07/03/2003 | WO2002016340A8 Aminoalkoxybenzoyl-benzofuran or benzothiophene derivatives, method for preparing same and compositions containing same |
| 07/03/2003 | US20030125800 Drug-delivery endovascular stent and method for treating restenosis |
| 07/03/2003 | US20030125659 Dosage of transdermal delivery systems |
| 07/03/2003 | US20030125657 Comprises ligand for human immunoglobulin for immunoapheresis, which mimicks sequence of an adrenergic receptor structure |
| 07/03/2003 | US20030125615 Homing of autologous cells to a target zone in tissue using active therapeutics or substances |
| 07/03/2003 | US20030125565 2,5-dioxoimidazolidine or 2-thio-5-oxoimidazolidine derivatives suitable for the therapy and prophylaxis of inflammatory disorders, for example of rheumatoid arthritis, or of allergic disorder |
| 07/03/2003 | US20030125559 Methods for synthesizing ether compounds and intermediates therefor |
| 07/03/2003 | US20030125523 Novel neuropilin/growth factor complexes and uses thereof |
| 07/03/2003 | US20030125391 Pharmaceutical solutions of modafinil compounds |
| 07/03/2003 | US20030125368 (1,2,4) triazol-1-yl)-benzenesulfonyl derivatives useful to treat osteoarthritis, rheumatoid arthritis, colon cancer and Alzheimer's disease, in mammals; cyclooxygenase (COX)-2 inhibitor |